Mpex Pharmaceuticals, Inc.
Records under this name other than patents Mpex Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Back to Mpex Pharmaceuticals, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,524,734 | Aerosolized fluoroquinolones and uses thereof Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,524,735 | Aerosolized fluoroquinolones and uses thereof Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,546,423 | Aerosolized fluoroquinolones and uses thereof Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 7,838,532 | Aerosolized fluoroquinolones and uses thereof Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 10,722,519 | Aerosol fluoroquinolone formulations for improved pharmacokinetics Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 11,020,481 | Topical use of levofloxacin for reducing lung inflammation Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 9,326,936 | Aerosol fluoroquinolone formulations for improved pharmacokinetics Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,629,139 | Topical use of Levofloxacin for reducing lung inflammation Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 9,700,564 | Use of aerosolized levofloxacin for treating cystic fibrosis Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 10,792,289 | Use of aerosolized levofloxacin for treating cystic fibrosis Formerly held In force · From the USPTO record | In force | From the USPTO record |